Estate Counselors, LLC Amgen Inc Transaction History

Estate Counselors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$218.65 - $271.46 $920,516 - $1.14 Million	4,210 New	4,210 $1.13 Million
Q1 2021 May 06, 2021	SELL	$221.91 - $258.6 $905,392 - $1.06 Million	-4,080 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $376,501 - $448,345	1,740 Added 74.36%	4,080 $938,000
Q3 2020 Oct 28, 2020	BUY	$234.65 - $260.95 $2,346 - $2,609	10 Added 0.43%	2,340 $595,000
Q2 2020 Aug 07, 2020	BUY	$197.81 - $242.74 $11,868 - $14,564	60 Added 2.64%	2,330 $549,000
Q1 2020 Apr 28, 2020	BUY	$182.24 - $241.7 $413,684 - $548,659	2,270 New	2,270 $460,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Estate Counselors, LLC, based on Form 13F filings with the SEC.

Stay updated on Estate Counselors, LLC with notifications on news.